Is Polymet Mining Corp (POM) Stock a Good Investment?
Learn more about Polymet Mining Corp's (POM) stock grades for Momentum and Growth and determine whether this Metals & Mining - Diversified stock meets your investment needs.Cynthia McLaughlin
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Pomdoctor Limited, through its subsidiaries, offers an online B2C portal to sell pharmaceutical products. The company develops an online medical services platform for chronic diseases in China. The company focuses on chronic disease management and pharmaceutical services and offers platform for medical services, which connects patients to doctors and pharmaceutical products. The company in involved in internet hospital and pharmaceutical supply chain, connecting users, pharmacies, suppliers, medical professionals, and other healthcare participants. The company was founded in 2010 and is headquartered in Guangzhou, China.
Commentary & Analysis
Financial Summary
| Share Statistics | POM | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $6.4 | $1,687.3 | 4% |
|
| Shares Out (Mil) | 0.6 | 77.7 | 3% |
|
| Institutional Ownership | 1.8% | 87.7% | 3% |
|
| Float (Mil) | 3.5 | 56.1 | 9% |
|
| Beta | na | 0.81 | na |
|
| Avg Daily Volume (000s) | 26 | 614 | 23% |
|
| Price Change (52-week) |
na | 76.5% | na |
|
| Growth | POM | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 21.5% | 10.6% | 83% |
|
| Net Income (5yr) | 5.0% | (0.3%) | 47% |
|
| EPS (5yr) | (6.4%) | 3.0% | 24 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | 16.5% | (17.3%) | 76% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | POM | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $57 | $1,505 | 21% |
|
| Net Income (TTM) (Mil) | ($30) | $26 | 21% |
|
| EPS (TTM) | ($9.419) | $0.200 | 5% |
|
| Operating Cash Flow (TTM) (Mil) | ($21) | $157 | 14% |
|
| Net Cash Flow (TTM) (Mil) | $-0 | $2 | 42% |
|
| Long-Term Debt (Q1) (Mil) | $53 | $374 | 39% |
|
| Enterprise Value (Q1) (Mil) | $66 | $2,284 | 18% |
|
| Valuation | POM | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 2.90 | na |
|
| P/E | na | 25.2 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.0 | na |
|
| Ratios | POM | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 12.0% | 27.6% | 11% |
|
| Net Margin | (90.2%) | 1.2% | 8% |
|
| ROA | (262.9%) | 2.1% | 1% |
|
| ROE | 16.6% | 6.9% | 74% |
|
| Liabilities to Assets | 547.5% | 60.8% | 100% |
|
| F-Score | 3 | 5 | 18% |
|
Pomdoctor Limited did not pass any screens on 10/2/2026.
